Summary Approximately 70% of patients with prostate cancer develop bone metastases in the advanced state of the disease. In the present study, we sought to test the hypothesis that prostatic cancer cells produce factors that inhibit the mineralisation process in vitro, decreasing the content of type I collagen in rat fetal calvaria osteoblasts. We investigated the capacity of conditioned media (CM) from the human prostatic tumour cell line PC-3 to inhibit the expression of the differentiation programme on osteoblasts in culture, with a primary focus on type I collagen synthesis and degradation. Our results show that PC-3 CM inhibits collagen synthesis and stimulates the production of interstitial collagenase from osteoblasts. A consequential decrease in the content of immunoreactive type I collagen was observed. We have previously demonstrated that PC-3 CM blocks osteoblast differentiation in culture. We propose that under the effect of factors present in PC-3 CM, osteoblastic cells retain the undifferentiated phenotype.
The skeleton is the major site of metastasis for prostate cancer (Chiarodo, 1991) . This metastasis -generally associated with poor prognosis -induces an osteoblastic reaction in vitro, characterised by an increased osteoblast proliferation (Koutsilieris et al., 1987a) . In vivo, prostate cells produce a sclerotic reaction in the infiltrated bone and impairment of the mineralisation process (Charhon et al., 1983) . The decreased mineral deposition could be partly explained by a decreased bioavailability of the nucleator proteins or by a lower concentration of structural collagen (Roach, 1994) .
Type I collagen constitutes the major extracellular matrix protein of bone. It makes up between 60% and 70% of the organic component and between 20% and 30% of its total dry mass (Glimcher, 1984) . Functionally, type I collagen has been described as an essential protein for the architecture of bone and the scaffold into which mineral is accumulated (Bindermann et al., 1979) . The relationships between collagen accumulation and matrix mineralisation may be examined in vitro as several reports have demonstrated the ability of cultured osteoblasts to produce a calcified matrix (EscarotCharrier et al., 1983; Owen et al., 1990a,b) . Studies using transmission electron microscopy have demonstrated that mineral deposition occurs in association with collagen fibres (Gerstenfeld et al., 1988) . Hence, any alteration of the collagen architecture on the bone might result in an impairment of mineralisation.
Using primary cultures of rat fetal calvaria osteoblasts, we have previously shown that factor(s) present in medium conditioned by the human prostatic cell line PC-3, stimulate cell proliferation and block the differentiation pattern of preosteoblasts (Martinez et al., 1996) . As a result of this treatment, cells retain traits of the undifferentiated precursors expressing an unmineralised phenotype. Using the same system, it has been shown that PC-3 CM stimulates osteoblast proliferation by a mechanism that is different to that of known bone mitogens transforming growth factor (TGF-f,), insulin-like growth factor (IGF-I) and IGF-II (Perkel et al., 1990) . The aminoterminal end of the molecule of urokinase-like plasminogen activator (u-PA), a component of PC-3 CM, has been implicated as the main mitogenic stimulus (Rabbani et al., 1990 until a concentration of 100-200 ig ml-'. Concentrated CM was diluted with PBS and dialysed against PBS overnight with a 10 kDa cut-off membrane.
Mineral histochemistry
In situ calcium phosphate determination was performed by silver staining (Clark, 1981) . Cellular monolayers were washed twice with cold PBS and fixed with 10% formaldehyde for 30 min. Once fixed, the cells were washed with distilled water and incubated with 2% silver nitrate for 10 min in darkness. Cells were extensively washed with distilled water and exposed to brilliant light for 15 min. Cells were then dehydrated with ethanol (100%) and airdried.
Collagen synthesis
In these experiments CM from PC-3 prostate cells (PC-3) was added (20 jug ml-') on day 4 of culture. Labelling was performed during the last 48 h of each incubation time at 37°C with 5 pCi ml-' [3H]proline (20 Ci mmol-'; ICN Biochemicals, Irvine, CA, USA) in a-MEM medium containing 1% FCS, and 50 Mg ml-' of both ascorbic acid and f,-aminopropionitrile. After the labelling period, the culture medium was harvested and processed for the determination of labelled collagen and non-collagen proteins using a collagenase-sensitive assay. This assay was performed using collagenase type VII (Sigma), which is a high-purity, chromatographically purified enzyme, and essentially free of non-specific proteases. The net production of collagen, represented by the amount of collagen (%) Figure 1 shows, nodules of mineral deposition in control cultures start to appear from day 12 of incubation and markedly increase with the time of culture. In contrast, PC-3 CM-treated cultures show only marginal calcium accumulation. At the end of the experimental period (23 days), few nodules of mineralisation were observed in PC-3 CM-treated cells. Calcium accumulation was 10-fold higher in control cultures between days 5 and 23, whereas accumulation was 2-fold higher in PC3-CM-treated cells (data not shown, Martinez et al., 1996) .
Collagen synthesis -an early marker of osteoblast differentiation -was estimated as [3H]proline incorporation into collagenase-sensitive proteins, and was measured on five different days that represent different steps in the differentiation pattern of osteoblasts. Results in Figure 2 show that collagen synthesis increases from day 7 at the time when ascorbic acid was added to the cultures, and decrease sharply at day 15. PC-3 CM-treated cultures display a lower capacity to synthesise collagen, which is more evident on days 9 and 11.
Osteoblast capacity to synthesise and release interstitial collagenase was assessed in cultures incubated with increasing concentrations of PC-3 CM. As Figure 3 shows, on day 11 of culture osteoblasts in the absence of PC-3 CM release only a small amount of active interstitial collagenase. In contrast, osteoblasts incubated with increasing concentrations of PC-3 CM (from 5 to 30 ,ug ml-') secrete a significant amount of active enzyme that increases in proportion to the concentration of PC-3 CM.
In order to confirm that the decreased synthesis and a stimulated degradation rate result in a lower accumulation of type I collagen in osteoblast cultures, we determined type I collagen content in control and PC-3 CM cultures. As Figure   The experiments presented in this study were conducted to investigate the effect of media conditioned by PC-3 cells on interstitial collagen turnover of rat fetal calvaria osteoblasts in culture, and the relationship of this phenomena with osteoblast mineralisation.
PC-3 cells correspond to a cell line that secretes soluble J. factors that specifically stimulate osteoblast-like cells and has been used as a model for the interaction between invasive prostate cells and bone (Koutsilieris et al., 1987) . A reciprocal and functionally coupled relationship between proliferation and differentiation has been proposed in rat fetal calvaria cells in culture (Stein and Lian, 1993) . A threestep temporal pattern consisting of the amplification of a proliferative pool, a period in which cells produce an extracellular matrix and a period during which mineralisation occurs, has been defined (Owen et al., 1990a) . In addition we have previously characterised (Martinez et al., 1996) , using specific biochemical markers, that in our culture system the early proliferative phase takes place between days 1 and 6, the extracellular matrix phase occurs during days 6 to 12 and the mineralisation phase takes place after day 12. Therefore, the sampling days used in the present study are representative of each one of these phases.
In a recent report, we demonstrated that rat fetal calvaria osteoblasts in culture incubated with PC-3 CM do not progress into the differentiation pathway, maintaining this undifferentiated unmineralised phenotype. It is not yet clear if this blockade on differentiation is the result of specific inhibition of the differentiation pattern, or is the expression of the maintenance of the cells in a proliferative status that inhibits activation of differentiation genes (Martinez et al., 1996) .
Results from the present study indicate that osteoblast cells cultured in the presence of PC-3 CM do not express the mineralised phenotype and have a lower capacity to synthesise collagen during the proliferative phase of the culture. In addition, cells acquire the capacity to produce and secrete an interstitial 65 kDa collagenase. As a consequence, total accumulation of type I collagen decreases and mineralisation does not take place.
A functional relationship between collagen synthesis during the proliferation phase and the expression of the osteoblast phenotype has been proposed by Owen et al. (1990a) . These studies point out that a lower deposition of type I collagen caused by a low concentration of ascorbic acid in the culture medium is associated with the maintenance of a proliferative state. Furthermore, increased doses of ascorbic acid resulted in a dose-dependent down-regulation of proliferation, increased collagen synthesis and increased mineralisation. In a recent report, Lynch et al. (1995) measured osteoblast proliferation and gene expression associated at the proliferative state, on cells attached on type I collagen films. The authors described that cells seeded in collagen proliferated at a lower rate, and genes normally expressed at maximal levels during the proliferative period were down-modulated. In these cases, external modifications of the extracellular matrix (ECM) rate of synthesis produce a regulation of cell proliferation. Interestingly, our results could represent an alternative to this view, i.e. an externally produced prolongation of the proliferative state generates a down-regulation of processes responsible for establishment of collagen matrix.
Interstitial collagenase cleaves the native triple helix of type I collagen into three-quarter-and one-quarter-length fragments, which denature into randomly coiled polypeptide chains at physiological temperature (Sakai and Gross, 1967) . Production of collagenase by bone cells is controlled by a variety of bone-resorbing agents that include retinoic acid, parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3, prostaglandin E2, interleukin 1 among others (Delaisse et al., 1988; Varghesse et al., 1994) . In cultured bone cells of human origin it has been proposed that cell differentiation is associated with a restrained capacity for metalloproteinase biosynthesis (Rifas et al., 1994) . In the fetal rat model, however, there is no evidence that a similar phenomenon occurs. Nevertheless, it is worth noting that: (a) the transcription factor AP-1 is responsible for enhancing transcription of collagenase in response to growth factors, cytokines, tumour promoters, carcinogens and overexpression of certain oncogenes (Angel and Karin, 1991) , and (b) in fetal rat osteoblasts in culture AP-1 binding activity is observed primarily in the proliferating state and dramatically decreases at the initiation of ECM maturation before mineralisation (Owen et al., 1990b) .
In our results, collagenase activity was measured on day 11, the time that corresponds to the maximum level of type I collagen synthesis, and the point where the accumulation rate of type I collagen begins to decrease in PC-3 CM-treated cultures. At this stage, we observed that collagenase activity in control cells is only marginal, which is in agreement with a presumed genetic control of the transcription of the enzyme. On the other hand, as we have proposed that fetal rat osteoblasts cultured in the presence of PC-3 CM tend to maintain the undifferentiated phenotype retaining some proliferative status (Martinez et al., 1996) , we suggest that with these experimental conditions the expression of genetic controls that down-regulated proliferation might not be fully operative and therefore the stimuli on the expression of interstitial collagenase would be maintained with the consistent increase in activity.
Results described suggest that factor(s) present in PC-3 CM could alter collagen turnover in osteoblasts in culture. As a result of this, two phenotypic traits are expressed: a lower accumulation of type I collagen and the de novo expression on an interstitial collagenase. Although no extensive characterisation has been made regarding the factor(s) present in PC3-CM that would be responsible for blockade in osteoblast differentiation, we have observed that this putative factor(s) is heat sensitive (100°C for 10 min), and has a molecular weight larger than 10 kDa as it is retained by the dialysing membrane.
